Cell Reports (Oct 2018)

Mutations in Craniosynostosis Patients Cause Defective Interleukin-11 Receptor Maturation and Drive Craniosynostosis-like Disease in Mice

  • Maria Agthe,
  • Julian Brügge,
  • Yvonne Garbers,
  • Marieke Wandel,
  • Birte Kespohl,
  • Philipp Arnold,
  • Charlotte M. Flynn,
  • Juliane Lokau,
  • Samadhi Aparicio-Siegmund,
  • Christian Bretscher,
  • Stefan Rose-John,
  • Georg H. Waetzig,
  • Tracy Putoczki,
  • Joachim Grötzinger,
  • Christoph Garbers

Journal volume & issue
Vol. 25, no. 1
pp. 10 – 18.e5

Abstract

Read online

Summary: Premature closure of the sutures that connect the cranial bones during development of the mammalian skull results in a phenotype called craniosynostosis. Recently, several craniosynostosis patients with missense mutations within the gene encoding the interleukin-11 receptor (IL-11R) have been described, but the underlying molecular mechanisms have remained elusive. IL-11 is a cytokine that has a crucial role in bone remodeling and activates cells via binding to the IL-11R. Here, we show that patient mutations prevented maturation of the IL-11R, resulting in endoplasmic reticulum retention and diminished cell surface appearance. Disruption of a conserved tryptophan-arginine zipper within the third domain of the IL-11R was the underlying cause of the defective maturation. IL-11 classic signaling via the membrane-bound receptor, but not IL-11 trans-signaling via the soluble receptor, was the crucial pathway for normal skull development in mice in vivo. Thus, the specific therapeutic inhibition of IL-11 trans-signaling does not interfere with skull development. : Mutations within the IL-11R cause craniosynostosis, a malformation of the skull. Agthe et al. show that some of these mutations prevent maturation of the IL-11R and identify structural traits whose disturbance causes misfolding of the receptor. They find that signaling via the membrane-bound IL-11R is required for skull formation. Keywords: interleukin-11, development, craniosynostosis, gp130, interleukin-6, osteoclast, trans-signaling, endoplasmic reticulum